About Elfin Drugs
Elfin Drugs is a company based in Sahibzada Ajit Singh Nagar (India) founded in 2011 by Dinesh Agarwal. It operates as a B2B. The company has 19 employees as of March 31, 2024. Elfin Drugs offers products and services including Ibuprofen 400MG Tablet, Azithromycin Oral Suspension, and Multivitamin Drops. Elfin Drugs operates in a competitive market with competitors including Akums, Jubilant Life Sciences, Recipharm, Unither and Nectar Lifesciences, among others.
- Headquarter Sahibzada Ajit Singh Nagar, India
- Employees 19 as on 31 Mar, 2024
- Founders Dinesh Agarwal
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Elfin Drugs Private Limited
- Date of Incorporation 25 Apr, 2005
- Jurisdiction Mohali, Punjab, India
-
Annual Revenue
$2.48 M (USD)14.98as on Mar 31, 2024
-
Net Profit
$24.65 K (USD)20.89as on Mar 31, 2024
-
EBITDA
$266.32 K (USD)26.04as on Mar 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
19
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Elfin Drugs
Elfin Drugs offers a comprehensive portfolio of products and services, including Ibuprofen 400MG Tablet, Azithromycin Oral Suspension, and Multivitamin Drops.
Tablet for managing pain and inflammation effectively.
Suspension for treating bacterial infections.
Drops providing essential vitamins and minerals.
Funding Insights of Elfin Drugs
Detailed funding history for Elfin Drugs
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Elfin Drugs
Investment portfolio details for Elfin Drugs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Elfin Drugs
Detailed financials for Elfin Drugs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Elfin Drugs Comparisons
Peer comparison for Elfin Drugs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Elfin Drugs
Elfin Drugs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Akums, Jubilant Life Sciences, Recipharm, Unither and Nectar Lifesciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
Detailed competitors of Elfin Drugs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Elfin Drugs
Complete news archive for Elfin Drugs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Elfin Drugs
Elfin Drugs was founded in 2011.
Elfin Drugs is headquartered in Sahibzada Ajit Singh Nagar, India. It is registered at Sahibzada Ajit Singh Nagar, Punjab, India.
Dinesh Agarwal is the current CEO of Elfin Drugs. They have also founded this company.
As of Mar 31, 2024, the latest employee count at Elfin Drugs is 19.
Annual revenue of Elfin Drugs is $2.48M as on Mar 31, 2024.
Elfin Drugs Private Limited is a pharmaceutical manufacturer based in Mohali, Punjab, India, with facilities in Baddi. They produce and export a wide range of products including tablets, capsules, injectables, syrups, and ointments, following WHO-GMP guidelines for quality. The company serves international clients in countries like Georgia and Iraq, focusing on effective, clinically tested medicines through advanced manufacturing processes.
Elfin Drugs's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Elfin Drugs offers Ibuprofen 400MG Tablet, Azithromycin Oral Suspension, and Multivitamin Drops.